A
Abhishek Niroula
Researcher at Harvard University
Publications - 54
Citations - 1220
Abhishek Niroula is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 13, co-authored 34 publications receiving 546 citations. Previous affiliations of Abhishek Niroula include Broad Institute & Lund University.
Papers
More filters
Journal ArticleDOI
PON-P2: Prediction Method for Fast and Reliable Identification of Harmful Variants
TL;DR: A new computational tool, PON-P2, for classification of amino acid substitutions in human proteins, which is a machine learning-based classifier and groups the variants into pathogenic, neutral and unknown classes, on the basis of random forest probability score.
Journal ArticleDOI
Variation Interpretation Predictors: Principles, Types, Performance, and Choice.
Abhishek Niroula,Mauno Vihinen +1 more
TL;DR: The different types of predictors and their applications for variation interpretation are discussed, including generic tolerance (pathogenicity) predictors for filtering harmful variants and Gene/protein/disease‐specific tools available for some applications.
Journal ArticleDOI
Distinction of lymphoid and myeloid clonal hematopoiesis
Abhishek Niroula,Abhishek Niroula,Abhishek Niroula,Aswin Sekar,Mark A. Murakami,Mark Trinder,Mark Trinder,Mridul Agrawal,Waihay J. Wong,Waihay J. Wong,Alexander G. Bick,Alexander G. Bick,Mesbah Uddin,Mesbah Uddin,Christopher J. Gibson,Christopher J. Gibson,Gabriel K. Griffin,Gabriel K. Griffin,Michael C. Honigberg,Michael C. Honigberg,Seyedeh M. Zekavat,Seyedeh M. Zekavat,Kaavya Paruchuri,Pradeep Natarajan,Pradeep Natarajan,Benjamin L. Ebert,Benjamin L. Ebert,Benjamin L. Ebert +27 more
TL;DR: In this article, the authors performed an integrated analysis of gene mutations associated with hematologic malignancies detected in hematopoietic cells of healthy individuals, referred to as CH of indeterminate potential (CHIP), and found that myeloid and lymphoid gene mutations were associated with risk of lineage-specific malignancy.
Journal ArticleDOI
Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women.
Michael C. Honigberg,Seyedeh M. Zekavat,Seyedeh M. Zekavat,Abhishek Niroula,Abhishek Niroula,Gabriel K. Griffin,Gabriel K. Griffin,Alexander G. Bick,Alexander G. Bick,James P. Pirruccello,Tetsushi Nakao,Eric A. Whitsel,Leslie V. Farland,Cecelia A. Laurie,Charles Kooperberg,JoAnn E. Manson,JoAnn E. Manson,Stacey Gabriel,Peter Libby,Alexander P. Reiner,Benjamin L. Ebert,Benjamin L. Ebert,Pradeep Natarajan +22 more
TL;DR: Natural premature menopause may serve as a risk signal for predilection to develop CHIP and CHIP-associated cardiovascular disease among postmenopausal women.
Journal ArticleDOI
How good are pathogenicity predictors in detecting benign variants
Abhishek Niroula,Mauno Vihinen +1 more
TL;DR: While these tools had excellent performance, the poorest method predicted more than one third of the benign variants to be disease-causing, which allows choosing reliable methods for benign variant interpretation, for both research and clinical purposes, as well as provide a benchmark for method developers.